Učitavanje...
SGLT2i: beyond the glucose-lowering effect
Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of glucose-lowering drug that can reduce blood glucose by inhibiting its reabsorption in proximal tubules and by promoting urinary glucose excretion. SGLT2i are widely used in the clinical treatment of type 2 diabetes mellitus (T2DM)....
Spremljeno u:
| Izdano u: | Cardiovasc Diabetol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320582/ https://ncbi.nlm.nih.gov/pubmed/32590982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01071-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|